JALALI, F.; MOSLEMI, D.; FARJAM, A. First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors. Reports of Radiotherapy and Oncology, v. 2, n. 1, p. 1-6, 24 jan. 2015.